Zum Titel springen


Medicines Development


Universität Basel UNIBAS


Basel (BS)




Universitäre Hochschulen UH - Weiterbildung: Lehrgänge

Zeitliche Beanspruchung



Gesundheit, Pflege, Medizin





Aktualisiert 24.02.2023


Beschreibung des Angebots

The European Center of Pharmaceutical Medicine (ECPM) designs and organizes the Master of Advanced Studies in Medicines Development program, together with partnering universities throughout Europe and other health care partner organizations. The program emphasizes integrated drug development, which is science-based, innovative, efficient and of high quality – leading to better and safer medical products for patients.

The ECPM belongs to the Department of Public Health of the Medical Faculty at the University of Basel and is accredited as “Centre of Excellence” by the Innovative Medicines Initiative (IMI) PharmaTrain Executive Board.

All ECPM courses are accredited by IMI PharmaTrain and the International Federation of Associations of Pharmaceutical Physicians (IFAPP) by following the agreed syllabus and quality assurance, and are certified by the University of Basel within the Bologna Title System.

Aufbau der Ausbildung

The program is structured in modules, which allows it to be completed next to working full- or part-time. Students can enroll in both the ECPM course and the master program.

In total, the Master of Advanced Studies requires a minimum of 60 ECTS.

30 ECTS will be accredited by successfully completing the two-year ECPM Diploma Course - a well-established postgraduate education and training program - and acquiring the Diploma of Advanced Studies (DAS).

20 ECTS will be accredited for completing the master modules selected from the Continuing Professional Development (CPD) short courses list. These can be chosen by preference either from the ECPM CPD short course program, from other course providers or partner universities which offer training relevant to drug development sciences and the IMI PharmaTrain syllabus.

The remaining 10 ECTS will be accredited for writing and submitting a master thesis.





The ECPM Advanced Studies degrees are targeted at representatives from the pharmaceutical industry, service industry, academic and government decision- and policy-makers who already have a good understanding of the basics of drug development and will benefit from a more in-depth, comprehensive and systematic immersion into modern medical product and device development, regulation and market introduction.

In order to enroll in the ECPM Diploma Course and pursue the Master of Advanced Studies, applicants must have a higher university degree, such as a Master’s, MD, PharmD or PhD. Applicants should have a primary interest in medical product discovery, development, regulation and health care system. The program is particularly aimed at professionals who are involved in the drug development process and have already at least one to two years working experience. Applications sur dossier are possible on an individual basis.


The tuition fee for the Master of Advanced Studies in Medicine Development is a follows:

  • ECPM Diploma Course (6 modules; 30 ECTS; CHF 14'750.- or the applicable reduced fee)
  • Master Modules can be either chosen from the ECPM Continuing Professional Development (CPD) short courses program or from other Universities (20 ECTS; tuition fee depends on the courses chosen and the course provider)
  • Master Thesis, Final Exam and Master Diploma (10 ECTS; CHF 3'500.-)


  • Master of Advanced Studies MAS

Master of Advanced Studies (MAS) Medicines Development, University of Basel

Praktische Hinweise

Ort / Adresse

  • Basel (BS)

Zeitlicher Ablauf


Admission is possible at any time

Zeitliche Beanspruchung

  • Teilzeit


  • Englisch


Auskünfte / Kontakt

European Center of Pharmaceutical Medicine
University of Basel
Institute of Pharmaceutical Medicine
Klingelbergstrasse 61
CH-4056 Basel

Tel. +41 61 207 19 50

Der Studiengang ist Teil der berufsbegleitenden Weiterbildung der Universität Basel.